Publication:
Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors

dc.contributor.authorZhang, Jianhua
dc.contributor.authorTao, Ran
dc.contributor.authorCampbell, Katherine F
dc.contributor.authorCarvalho, Juliana L
dc.contributor.authorRuiz, Edward C
dc.contributor.authorKim, Gina C
dc.contributor.authorSchmuck, Eric G
dc.contributor.authorRaval, Amish N
dc.contributor.authorda Rocha, André Monteiro
dc.contributor.authorHerron, Todd J
dc.contributor.authorJalife, Jose
dc.contributor.authorThomson, James A
dc.contributor.authorKamp, Timothy J
dc.contributor.funderNational Institutes of Health (Estados Unidos)
dc.date.accessioned2019-06-04T12:46:20Z
dc.date.available2019-06-04T12:46:20Z
dc.date.issued2019
dc.description.abstractCardiac fibroblasts (CFs) play critical roles in heart development, homeostasis, and disease. The limited availability of human CFs from native heart impedes investigations of CF biology and their role in disease. Human pluripotent stem cells (hPSCs) provide a highly renewable and genetically defined cell source, but efficient methods to generate CFs from hPSCs have not been described. Here, we show differentiation of hPSCs using sequential modulation of Wnt and FGF signaling to generate second heart field progenitors that efficiently give rise to hPSC-CFs. The hPSC-CFs resemble native heart CFs in cell morphology, proliferation, gene expression, fibroblast marker expression, production of extracellular matrix and myofibroblast transformation induced by TGFβ1 and angiotensin II. Furthermore, hPSC-CFs exhibit a more embryonic phenotype when compared to fetal and adult primary human CFs. Co-culture of hPSC-CFs with hPSC-derived cardiomyocytes distinctly alters the electrophysiological properties of the cardiomyocytes compared to co-culture with dermal fibroblasts. The hPSC-CFs provide a powerful cell source for research, drug discovery, precision medicine, and therapeutic applications in cardiac regeneration.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipJ.L.C. received funding from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior and Fundação de Amparo à Pesquisa do Distrito Federal. The work was funded by NIH R01 HL129798 (T.J.K.); NIH U01 HL134764 (T.J.K.); S10RR025644 (T.J.K.); and the UW Institute for Clinical and Translational Research, grant UL1TR000427, from the Clinical and Translational Science Award of the NCATS/NIH.es_ES
dc.format.number1es_ES
dc.format.page2238es_ES
dc.format.volume10es_ES
dc.identifier.citationNat Commun. 2019; 10(1):2238es_ES
dc.identifier.doi10.1038/s41467-019-09831-5es_ES
dc.identifier.e-issn2041-1723es_ES
dc.identifier.issn2041-1723es_ES
dc.identifier.journalNature communicationses_ES
dc.identifier.pubmedID31110246es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7726
dc.language.isoenges_ES
dc.publisherNature Publishing Groupes_ES
dc.relation.publisherversionhttps://doi.org/10.1038/s41467-019-09831-5es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Arritmias Cardíacases_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleFunctional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitorses_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication3281dd95-3aa7-46b8-857c-aca343b747c0
relation.isAuthorOfPublication.latestForDiscovery3281dd95-3aa7-46b8-857c-aca343b747c0

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
FunctionalCardiacFibroblastsDerived_2019.pdf
Size:
3.91 MB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
Supplementary_FunctionalCardiacFibroblastsDerived_2019.zip
Size:
102.5 MB
Format: